What is the recommended intramuscular dose of Toradol (ketorolac) for an adult patient with back pain and no significant contraindications to Non-Steroidal Anti-Inflammatory Drug (NSAID) use?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Intramuscular Dose of Ketorolac for Back Pain

For adults under 65 years with back pain, administer ketorolac 30 mg IM every 6 hours (maximum 120 mg/day), and for adults 65 years or older, use 15 mg IM every 6 hours (maximum 60 mg/day), with treatment duration not exceeding 5 days. 1

Standard Dosing Protocol

Adults Under 65 Years

  • 30 mg IM every 6 hours is the FDA-approved dose for multiple-dose treatment 1
  • Maximum daily dose: 120 mg 1
  • Single-dose option: 60 mg IM (for one-time use only) 1
  • Administer slowly and deeply into the muscle 1

Adults 65 Years or Older

  • 15 mg IM every 6 hours (reduced dose due to increased risk) 1
  • Maximum daily dose: 60 mg 1
  • Single-dose option: 30 mg IM 1
  • The American Geriatrics Society emphasizes extreme caution in this population due to increased risk of all NSAID-related adverse effects 2

Patients Under 50 kg (110 lbs) or with Renal Impairment

  • Use the reduced dosing regimen: 15 mg IM every 6 hours (maximum 60 mg/day) 1
  • These patients have the same risk profile as elderly patients 1

Critical Duration Limitation

  • Maximum treatment duration: 5 days for all patients 2, 1
  • Switch to oral NSAIDs or alternative analgesics as soon as possible 1
  • The National Comprehensive Cancer Network emphasizes that ketorolac should be used for the shortest duration necessary 2

Evidence Supporting Ketorolac for Back Pain

Efficacy Data

  • Ketorolac demonstrated superior efficacy compared to acetaminophen-codeine for acute low back pain in the emergency department, with comparable pain relief but significantly fewer adverse events 3
  • NSAIDs (including ketorolac) are superior to placebo for pain relief and functional improvement in acute low back pain 4
  • The American College of Physicians recommends NSAIDs as first-line agents for low back pain, noting they are slightly superior to acetaminophen 5

Analgesic Ceiling Effect

  • Research demonstrates an analgesic ceiling effect at doses as low as 7.5-10 mg, meaning higher doses do not provide additional pain relief 6, 7
  • Despite this evidence, the FDA-approved dosing remains 30 mg for standard adult patients, which should be followed for medicolegal reasons 1
  • A study in patients 65 years and older found no significant difference in pain relief between 15 mg and 30 mg doses 8

Pre-Administration Safety Assessment

Absolute Contraindications

  • Active peptic ulcer disease or gastrointestinal bleeding 2
  • Aspirin/NSAID-induced asthma 2
  • Pregnancy 2
  • Recent cerebrovascular hemorrhage 2
  • Perioperative pain in coronary artery bypass graft surgery 4

High-Risk Populations Requiring Caution

  • Age ≥60 years: Increased risk of all NSAID-related adverse effects 9
  • Renal impairment: Use 15 mg dose; ketorolac causes renal dysfunction in 8.7% of high-risk patients 9, 2
  • Compromised fluid status or dehydration: Correct hypovolemia before administration 1
  • History of peptic ulcer disease: 5% risk of recurrent bleeding within 6 months 4
  • Concurrent anticoagulant use: Increases GI bleeding risk 5-6 fold 4
  • Cardiovascular disease or hypertension: NSAIDs increase myocardial infarction risk 5

Mandatory Monitoring Requirements

Baseline Assessment (Before First Dose)

  • Blood pressure 9, 2
  • BUN and creatinine 9, 2
  • Liver function tests 9, 2
  • Complete blood count 9, 2
  • Fecal occult blood 9, 2

Discontinuation Criteria

  • Stop immediately if:
    • BUN or creatinine doubles 9
    • Hypertension develops or worsens 9
    • Liver function tests increase >3 times upper limit of normal 9
    • Any gastrointestinal bleeding occurs 9, 4

Onset and Duration of Action

  • Analgesic effect begins in approximately 30 minutes 1
  • Maximum effect occurs 1-2 hours after IM administration 1, 10
  • Duration of analgesic effect: 4-6 hours 1
  • Peak plasma concentrations achieved in 45-50 minutes 10

Multimodal Analgesia Strategy

For Breakthrough Pain

  • Do not increase ketorolac dose or frequency 1
  • Consider supplementing with low-dose opioids if not contraindicated 1
  • Acetaminophen can be safely alternated with ketorolac every 3 hours for more continuous coverage 9

Transition Strategy

  • After 5 days maximum, transition to oral NSAIDs (e.g., ibuprofen 400-800 mg every 6 hours, maximum 2400 mg/day) 4
  • Acetaminophen is a safer long-term alternative with fewer side effects, though slightly less effective 5

Common Pitfalls to Avoid

  • Avoid combining with other NSAIDs (including ibuprofen): Wait 6-8 hours after last ibuprofen dose before giving ketorolac due to additive toxicity without additional analgesic benefit 9
  • Do not mix in syringe with morphine sulfate, meperidine, promethazine, or hydroxyzine (causes precipitation) 1
  • Do not exceed 5-day duration: Risk-benefit ratio deteriorates significantly with prolonged use 4
  • Do not use standard doses in elderly or renally impaired patients: Always use reduced 15 mg dosing 1

References

Guideline

Ketorolac Dosage and Usage Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Maximum Daily Dosing of Ibuprofen in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Patterns of Ketorolac dosing by emergency physicians.

World journal of emergency medicine, 2017

Guideline

Safe Use of Toradol After Ibuprofen

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Ketorolac: a parenteral nonsteroidal antiinflammatory drug.

DICP : the annals of pharmacotherapy, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.